| Treating rare diseases: the challenge of orphan drugs |
|---|
| Orphan drugs are drugs used to treat rare diseases. In April 2025, NICE adopted new criteria for evaluating drugs for 'ultra rare' diseases. |
No abstract for this publication.
|
- Publication type:
- policy brief
- Publication language:
- English
- Publication date:
- 2025-07
- Publication URL:
- https://doi.org/10.58248/RR83
- Institute:
- Parliamentary Office of Science and Technology of the UK Parliament (POST)
- Country:
- United Kingdom of Great Britain & Northern Ireland
